Organisation paid for research Program year 2024 Source: CMS Open Payments

Key-Whitman Eye Center

Neither a doctor nor a teaching hospital

Research payments

$293,155

59 payments

Through program year 2024, Key-Whitman Eye Center is reported as receiving $293,155 in research payments, across 59 payments.

By program year

6 rows

Year	Kind	Amount	Payments
2024	Research	$49,905	4
2023	Research	$80,630	8
2022	Research	$98,975	15
2021	Research	$9,995	11
2020	Research	$16,445	10
2019	Research	$37,205	11

Breakdown

Who paid Research payments · program years 2019–2024

RxSight Inc $222,920 19 payments
Glaukos Corporation $70,235 40 payments

Studies the money was for Research payments · program years 2019–2024

Pmcs-002 $128,035 10 payments
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study $85,210 8 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $37,205 11 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $16,445 10 payments
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5 $9,995 11 payments
Clinical Outcomes of Patients Implanted with the Commercially Available RxSight Light Adjustable Lens (LAL) $9,675 1 payment
A Phase 3, Multi-center, Randomized, Double-masked, Placebo/Sham-controlled Study to Evaluate the Safety and Efficacy of Oxygen Enriched, Non-invasive Epithelium-on Corneal Collagen Cross-linking in Eyes with Keratoconus $2,000 1 payment
Prospective, Randomized Phase 3 Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, USP, 0.5% $500 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.